PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 5 days 20 hours 52 minutes
Individualizing Treatment Choices for Metastatic Melanoma: Which Therapy Is Best for Which Patient?
Go online to www.peervoice.com/h/pvr197 to view the entire programme with slides.
Fine-Tuning Management of Advanced NSCLC: Clinical Implications of EGFR Mutations and Histology
Go online to www.peervoice.com/h/pve72 to view the entire programme with slides.
The Evolving Treatment Landscape in Gastric Cancer: How Will Targeted Therapy Affect Clinical Practice?
Go online to www.peervoice.com/h/pve65 to view the entire programme with slides.
Expert Perspectives: Treating by Mutation and Histology in Advanced NSCLC
Expert Perspectives: Treating by Mutation and Histology in Advanced NSCLC
Expert Insights: A Practical Guide to ALK Testing in Advanced NSCLC
Expert Insights: A Practical Guide to ALK Testing in Advanced NSCLC
Tailoring Treatment for Breakthrough Cancer Pain: Insights From a Multidisciplinary Perspective
Go online to www.peervoice.com/h/pve66 to view the entire programme with slides.
Options to Reduce Risk of Febrile Neutropenia: How Do the Experts Decide?
Options to Reduce Risk of Febrile Neutropenia: How Do the Experts Decide?
Individualised Strategies to Achieve Cure for Patients With Chronic Hepatitis C and Advanced Liver Disease: Beyond "One Size Fits All"
Go online to www.peervoice.com/h/pvr186 to view the entire programme with slides.
Improving Outcomes in Acute Promyelocytic Leukaemia Through Early and Risk-Adapted Treatment
Go online to www.peervoice.com/h/pvr191 to view the entire programme with slides.
CLL Management in the Relapsed/Refractory Setting: A Look at Novel Targeted Agents on the Horizon
Go online to www.peervoice.com/h/pvs69 to view the entire programme with slides.